Skip to main content
. 2022 Apr 18;11(1):1115–1125. doi: 10.1080/22221751.2022.2059400

Figure 3.

Figure 3.

SARS-CoV-2 in the pancreas of COVID-19 patients. (A-B) SARS-CoV-2 receptors ACE2 and CD147 were diffusely expressed in the pancreas. In the non-COVID-19 control patient, ACE2 expression was higher in the exocrine gland, and CD147 was evenly expressed. In patients with COVID-19, ACE2 and CD147 expression was much higher in the endocrine gland. (C) SARS-CoV-2 spike antibody staining showed diffuse positive signals (brown) in the sample from the patient with COVID-19 but not in the non-COVID-19 control. (D) The SARS-CoV-2 nucleic acid probe showed positive staining (red particles) in the cytoplasm of pancreatic cells of a patient with COVID-19 but not in that of the non-COVID-19 control.